Developing an effective treatment for respiratory infections, including those resistant to antibiotics, was the ambition of the ALIPEX collaborative program made up of three French SMEs: ALAXIA, CREATIVE EURECOM and DTF medical. The aim of this collaboration: to offer new generation inhaled treatment to patients with cystic fibrosis. The transportable device developed by CREATIVE EURECOM is a mini-factory for manufacturing medicines at home. Since the drug has a very short shelf life, the device allows it to be synthesized just before its administration. This equipment is the first in the world to allow the development of a drug in an extemporaneous manner.

Read more (french): electrondor.electroniques.biz/overview-2019/

The post Creative Eurecom Winner in the “Health” category at the Technical Day of Electronics, Paris June 27th, 2019 first appeared on Creative Crossway.